DE3335185A1 - Verfahren zur herstellung eines inaktivierten impfstoffes gegen die aujeszkysche krankheit - Google Patents

Verfahren zur herstellung eines inaktivierten impfstoffes gegen die aujeszkysche krankheit

Info

Publication number
DE3335185A1
DE3335185A1 DE19833335185 DE3335185A DE3335185A1 DE 3335185 A1 DE3335185 A1 DE 3335185A1 DE 19833335185 DE19833335185 DE 19833335185 DE 3335185 A DE3335185 A DE 3335185A DE 3335185 A1 DE3335185 A1 DE 3335185A1
Authority
DE
Germany
Prior art keywords
virus
disease
inactivated
aujeszky
phylaxia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19833335185
Other languages
German (de)
English (en)
Inventor
László Dr. Farkas
Anna Dr. Forgács geb. Fulmer
Maria Dr. Kelemen geb. Szedö
András Dr. Makár
Tibor Dr. Budapest Perényi
Gábor Dr. Szabo
Ferenc Dr. Sólyom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PHYLAXIA OLTOANYAGTERMELOE
Original Assignee
PHYLAXIA OLTOANYAGTERMELOE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PHYLAXIA OLTOANYAGTERMELOE filed Critical PHYLAXIA OLTOANYAGTERMELOE
Publication of DE3335185A1 publication Critical patent/DE3335185A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE19833335185 1982-10-27 1983-09-28 Verfahren zur herstellung eines inaktivierten impfstoffes gegen die aujeszkysche krankheit Withdrawn DE3335185A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU823441A HU187421B (en) 1982-10-27 1982-10-27 Process for producing inactivated, adjuvated serum against aujeszky's illness

Publications (1)

Publication Number Publication Date
DE3335185A1 true DE3335185A1 (de) 1984-05-03

Family

ID=10964044

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19833335185 Withdrawn DE3335185A1 (de) 1982-10-27 1983-09-28 Verfahren zur herstellung eines inaktivierten impfstoffes gegen die aujeszkysche krankheit

Country Status (6)

Country Link
CS (1) CS253709B2 (hu)
DE (1) DE3335185A1 (hu)
FR (1) FR2535204B1 (hu)
GB (1) GB2129684B (hu)
HU (1) HU187421B (hu)
YU (1) YU211883A (hu)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR216081A1 (es) * 1976-07-02 1979-11-30 Dso Pharmachim Un metodo de preparar un mutante virosico avirulento a partir del virus de aujeszky

Also Published As

Publication number Publication date
YU211883A (en) 1987-04-30
CS253709B2 (en) 1987-12-17
GB2129684A (en) 1984-05-23
HU187421B (en) 1986-01-28
GB2129684B (en) 1986-06-18
GB8328368D0 (en) 1983-11-23
FR2535204A1 (fr) 1984-05-04
FR2535204B1 (fr) 1988-01-15
CS794483A2 (en) 1987-05-14

Similar Documents

Publication Publication Date Title
Gear, James,* De Meillon, Botha,* Measroch, V.* & Davis Rift valley fever in South Africa: 2: The occurrence of human cases in the orange free state, the north-western cape province, the western and southern transvaal: B: Field and laboratory investigations
DE2542792A1 (de) Verfahren zur erhoehung der antikoerpermenge in der milch von milchabsondernden rindern
DE4432338A1 (de) Impfstoff zur Verhinderung des reproduktiven und respiratorischen Syndroms bei Schweinen
DE3882599T2 (de) Hundecoronavirus-Impfstoff.
DE2713371C2 (hu)
Wiktor Virus vaccines and therapeutic approaches
DE2817299A1 (de) Verfahren zur herstellung eines attenuierten infektioese-gastroenteritis (tge)-virusstammes zur anwendung in lebendvakzinen
CH658192A5 (de) Tollwut-impfstoff und verfahren zu seiner herstellung.
DE2816942C2 (de) Impfstoff gegen Rhinitis atrophicans beim Schwein
DE2212277C3 (de) Verfahren zur Herstellung einer Totvaccine gegen infektiöse atrophische Rhinitis der Schweine
DE69615656T2 (de) Aviären infektiösen anämie mastgeflügel impfstoff
Ploeger et al. Production of dairy replacement stock in relation to level of exposure to gastrointestinal nematode infection in the first grazing season: second-year calves and heifers
DE3335185A1 (de) Verfahren zur herstellung eines inaktivierten impfstoffes gegen die aujeszkysche krankheit
DE3878982T2 (de) Abgeschwaechtes virus und impfstoffe davon zur verwendung gegen infektionen bei gefluegel, verursacht durch truthahn-rhinotracheitis-virus.
DE2520310A1 (de) Verfahren zur herstellung von immunisierender milch und/oder kolostrum
DE2602478A1 (de) Verfahren zur herstellung einer vaccine gegen die panleukopenie der katze
CH618091A5 (en) Method for the attenuation of virulent feline rhinotracheitis virus and use of this virus for the production of a vaccine
DE1692043C3 (de) Rhinopneumonitis-Vaccine und Verfahren zu deren Herstellung
DE1253412B (de) Verfahren zur Gewinnung eines Impfstoffes gegen infektioese Schweinegastroenteritis
AT234902B (de) Verfahren zur Herstellung einer Vaccine gegen Staupe
DE1792356C2 (de) Staupe-Kombinationsvaccinen und Verfahren zu ihrer Herstellung
DE2702634A1 (de) Verfahren zur herstellung einer vaccine gegen die panleukopenie der katze
DE69208854T2 (de) Impfstoff-Zubereitung zur Vorbeugung gegen bei Tieren durch Chlamydia psitacci verursachte Fehlgeburt
DE2225548A1 (de) Intravenoes vertraegliche staupe- und hepatitisvaccine
US3415926A (en) Equine encephalomyelitis vaccine

Legal Events

Date Code Title Description
8130 Withdrawal